Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response.

Hassane M, Jouan Y, Creusat F, Soulard D, Boisseau C, Gonzalez L, Patin EC, Heuzé-Vourc'h N, Sirard JC, Faveeuw C, Trottein F, Si-Tahar M, Baranek T, Paget C.

Mucosal Immunol. 2019 Oct 18. doi: 10.1038/s41385-019-0212-y. [Epub ahead of print]

PMID:
31628425
2.

Therapeutic Synergy Between Antibiotics and Pulmonary Toll-Like Receptor 5 Stimulation in Antibiotic-Sensitive or -Resistant Pneumonia.

Matarazzo L, Casilag F, Porte R, Wallet F, Cayet D, Faveeuw C, Carnoy C, Sirard JC.

Front Immunol. 2019 Apr 9;10:723. doi: 10.3389/fimmu.2019.00723. eCollection 2019.

3.

TLR9-mediated dendritic cell activation uncovers mammalian ganglioside species with specific ceramide backbones that activate invariant natural killer T cells.

Paget C, Deng S, Soulard D, Priestman DA, Speca S, von Gerichten J, Speak AO, Saroha A, Pewzner-Jung Y, Futerman AH, Mallevaey T, Faveeuw C, Gu X, Platt FM, Sandhoff R, Trottein F.

PLoS Biol. 2019 Mar 1;17(3):e3000169. doi: 10.1371/journal.pbio.3000169. eCollection 2019 Mar.

4.

Alteration of Flt3-Ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection.

Beshara R, Sencio V, Soulard D, Barthélémy A, Fontaine J, Pinteau T, Deruyter L, Ismail MB, Paget C, Sirard JC, Trottein F, Faveeuw C.

PLoS Pathog. 2018 Oct 29;14(10):e1007360. doi: 10.1371/journal.ppat.1007360. eCollection 2018 Oct.

5.

Interleukin-22 Immunotherapy during Severe Influenza Enhances Lung Tissue Integrity and Reduces Secondary Bacterial Systemic Invasion.

Barthelemy A, Sencio V, Soulard D, Deruyter L, Faveeuw C, Le Goffic R, Trottein F.

Infect Immun. 2018 Jun 21;86(7). pii: e00706-17. doi: 10.1128/IAI.00706-17. Print 2018 Jul.

6.

Type I IFN Receptor Signaling Controls IL7-Dependent Accumulation and Activity of Protumoral IL17A-Producing γδT Cells in Breast Cancer.

Patin EC, Soulard D, Fleury S, Hassane M, Dombrowicz D, Faveeuw C, Trottein F, Paget C.

Cancer Res. 2018 Jan 1;78(1):195-204. doi: 10.1158/0008-5472.CAN-17-1416. Epub 2017 Oct 25.

7.

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.

Ghinnagow R, De Meester J, Cruz LJ, Aspord C, Corgnac S, Macho-Fernandez E, Soulard D, Fontaine J, Chaperot L, Charles J, Soncin F, Mami-Chouaib F, Plumas J, Faveeuw C, Trottein F.

Oncoimmunology. 2017 Aug 18;6(9):e1339855. doi: 10.1080/2162402X.2017.1339855. eCollection 2017.

8.

Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy.

Ghinnagow R, Cruz LJ, Macho-Fernandez E, Faveeuw C, Trottein F.

Front Immunol. 2017 Jul 27;8:879. doi: 10.3389/fimmu.2017.00879. eCollection 2017. Review.

9.

Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses.

Macho-Fernandez E, Chekkat N, Ehret C, Thomann JS, De Giorgi M, Spanedda MV, Bourel-Bonnet L, Betbeder D, Heurtault B, Faveeuw C, Fournel S, Frisch B, Trottein F.

Int J Pharm. 2017 Sep 15;530(1-2):354-363. doi: 10.1016/j.ijpharm.2017.07.054. Epub 2017 Jul 22.

PMID:
28743554
10.

Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion regulates the γδT17 cell response in respiratory bacterial infections.

Hassane M, Demon D, Soulard D, Fontaine J, Keller LE, Patin EC, Porte R, Prinz I, Ryffel B, Kadioglu A, Veening JW, Sirard JC, Faveeuw C, Lamkanfi M, Trottein F, Paget C.

Mucosal Immunol. 2017 Jul;10(4):1056-1068. doi: 10.1038/mi.2016.113. Epub 2017 Jan 4.

PMID:
28051086
11.

Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza.

Barthelemy A, Ivanov S, Hassane M, Fontaine J, Heurtault B, Frisch B, Faveeuw C, Paget C, Trottein F.

MBio. 2016 Nov 1;7(6). pii: e01440-16. doi: 10.1128/mBio.01440-16.

12.

NKT Cell Hyporesponsiveness Leads to Unrestrained Accumulation of Marginal Zone B Cells in Hypercholesterolemic Apolipoprotein E-Deficient Mice.

Soh SY, Faveeuw C, Thiam CH, Khoo LH, Yeo KP, Lim SY, Lim HY, Ng JX, Angeli V.

J Immunol. 2016 Nov 15;197(10):3894-3904. Epub 2016 Oct 21.

13.

Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.

Barthelemy A, Ivanov S, Fontaine J, Soulard D, Bouabe H, Paget C, Faveeuw C, Trottein F.

Mucosal Immunol. 2017 Mar;10(2):460-469. doi: 10.1038/mi.2016.49. Epub 2016 May 25.

PMID:
27220813
14.

Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Goubard A, Loïez C, Abe J, Fichel C, Herwegh S, Faveeuw C, Porte R, Cayet D, Sebbane F, Penet S, Foligné B, Desreumaux P, Saito H, Sirard JC, Simonet M, Carnoy C.

Infect Immun. 2015 May;83(5):2053-64. doi: 10.1128/IAI.02339-14. Epub 2015 Mar 9.

15.

Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.

Macho-Fernandez E, Cruz LJ, Ghinnagow R, Fontaine J, Bialecki E, Frisch B, Trottein F, Faveeuw C.

J Immunol. 2014 Jul 15;193(2):961-9. doi: 10.4049/jimmunol.1303029. Epub 2014 Jun 9.

16.

Type I NKT-cell-mediated TNF-α is a positive regulator of NLRP3 inflammasome priming.

Chow MT, Duret H, Andrews DM, Faveeuw C, Möller A, Smyth MJ, Paget C.

Eur J Immunol. 2014 Jul;44(7):2111-20. doi: 10.1002/eji.201344329. Epub 2014 Apr 29.

17.

Optimization of natural killer T cell-mediated immunotherapy in cancer using cell-based and nanovector vaccines.

Faveeuw C, Trottein F.

Cancer Res. 2014 Mar 15;74(6):1632-8. doi: 10.1158/0008-5472.CAN-13-3504. Epub 2014 Mar 5. Review.

18.

Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection.

Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, Chabalgoity JA, Renauld JC, Eberl G, Benecke AG, Trottein F, Faveeuw C, Sirard JC.

J Infect Dis. 2014 Aug 1;210(3):493-503. doi: 10.1093/infdis/jiu106. Epub 2014 Feb 26.

PMID:
24577508
19.

Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, Fernandez EM, Blanc F, De Trez C, Van Maele L, Dumoutier L, Huerre MR, Eberl G, Si-Tahar M, Gosset P, Renauld JC, Sirard JC, Faveeuw C, Trottein F.

J Virol. 2013 Jun;87(12):6911-24. doi: 10.1128/JVI.02943-12. Epub 2013 Apr 17.

20.

Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide.

Ivanov S, Fontaine J, Paget C, Macho Fernandez E, Van Maele L, Renneson J, Maillet I, Wolf NM, Rial A, Léger H, Ryffel B, Frisch B, Chabalgoity JA, Sirard JC, Benecke A, Faveeuw C, Trottein F.

J Infect Dis. 2012 Sep 1;206(5):723-34. doi: 10.1093/infdis/jis413. Epub 2012 Jun 21.

PMID:
22723642
21.

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, Dumoutier L, Ryffel B, Renauld JC, Gosset P, Gosset P, Si-Tahar M, Faveeuw C, Trottein F.

J Biol Chem. 2012 Mar 16;287(12):8816-29. doi: 10.1074/jbc.M111.304758. Epub 2012 Jan 31.

22.

Spleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.

Bialecki E, Macho Fernandez E, Ivanov S, Paget C, Fontaine J, Rodriguez F, Lebeau L, Ehret C, Frisch B, Trottein F, Faveeuw C.

PLoS One. 2011;6(10):e26919. doi: 10.1371/journal.pone.0026919. Epub 2011 Oct 31.

23.

Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.

Delfortrie S, Pinte S, Mattot V, Samson C, Villain G, Caetano B, Lauridant-Philippin G, Baranzelli MC, Bonneterre J, Trottein F, Faveeuw C, Soncin F.

Cancer Res. 2011 Dec 1;71(23):7176-86. doi: 10.1158/0008-5472.CAN-11-1301. Epub 2011 Oct 28.

24.

A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.

Renneson J, Guabiraba R, Maillet I, Marques RE, Ivanov S, Fontaine J, Paget C, Quesniaux V, Faveeuw C, Ryffel B, Teixeira MM, Trottein F.

Am J Pathol. 2011 Oct;179(4):1872-83. doi: 10.1016/j.ajpath.2011.06.023. Epub 2011 Aug 16.

25.

Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.

Macho Fernandez E, Chang J, Fontaine J, Bialecki E, Rodriguez F, Werkmeister E, Krieger V, Ehret C, Heurtault B, Fournel S, Frisch B, Betbeder D, Faveeuw C, Trottein F.

Int J Pharm. 2012 Feb 14;423(1):45-54. doi: 10.1016/j.ijpharm.2011.04.068. Epub 2011 May 14.

PMID:
21575695
26.

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F.

J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. Erratum in: J Immunol. 2011 Aug 1;187(3):1515. Barba-Speath, Giovanna [corrected to Barba-Spaeth, Giovanna].

27.

Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels.

Lee-Chang C, Lefranc D, Salleron J, Faveeuw C, Allet C, Vermersch P, Oxombre B, Prin L.

Immunol Lett. 2011 Mar 30;135(1-2):108-17. doi: 10.1016/j.imlet.2010.10.006. Epub 2010 Oct 12.

PMID:
20946917
28.

Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages.

Trottein F, Schaffer L, Ivanov S, Paget C, Vendeville C, Cazet A, Groux-Degroote S, Lee S, Krzewinski-Recchi MA, Faveeuw C, Head SR, Gosset P, Delannoy P.

Glycoconj J. 2009 Dec;26(9):1259-74. doi: 10.1007/s10719-009-9244-y.

29.

Role of marginal zone B lymphocytes in invariant NKT cell activation.

Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, Faveeuw C.

J Immunol. 2009 May 15;182(10):6105-13. doi: 10.4049/jimmunol.0802273.

30.

Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.

Paget C, Bialecki E, Fontaine J, Vendeville C, Mallevaey T, Faveeuw C, Trottein F.

J Immunol. 2009 Feb 15;182(4):1846-53. doi: 10.4049/jimmunol.0802492.

31.

Role of natural killer T lymphocytes during helminthic infection.

Faveeuw C, Mallevaey T, Trottein F.

Parasite. 2008 Sep;15(3):384-8. Review.

32.

Pathogen induced regulatory cell populations preventing allergy through the Th1/Th2 paradigm point of view.

Roumier T, Capron M, Dombrowicz D, Faveeuw C.

Immunol Res. 2008;40(1):1-17. doi: 10.1007/s12026-007-0058-3. Review.

PMID:
18193360
33.

Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma.

Torres D, Paget C, Fontaine J, Mallevaey T, Matsuoka T, Maruyama T, Narumiya S, Capron M, Gosset P, Faveeuw C, Trottein F.

J Immunol. 2008 Jan 15;180(2):783-92.

34.

Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells.

Vanhoutte F, Paget C, Breuilh L, Fontaine J, Vendeville C, Goriely S, Ryffel B, Faveeuw C, Trottein F.

Immunol Lett. 2008 Feb 15;116(1):86-94. doi: 10.1016/j.imlet.2007.11.014. Epub 2007 Dec 17.

PMID:
18166232
35.

Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to control Schistosoma mansoni infection and pathology.

Vanhoutte F, Breuilh L, Fontaine J, Zouain CS, Mallevaey T, Vasseur V, Capron M, Goriely S, Faveeuw C, Ryffel B, Trottein F.

Microbes Infect. 2007 Nov-Dec;9(14-15):1606-13. Epub 2007 Sep 26.

PMID:
18023390
36.

Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.

Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, Sheehan KC, Capron M, Ryffel B, Faveeuw C, Leite de Moraes M, Platt F, Trottein F.

Immunity. 2007 Oct;27(4):597-609. Epub 2007 Oct 18.

37.

Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells.

Breuilh L, Vanhoutte F, Fontaine J, van Stijn CM, Tillie-Leblond I, Capron M, Faveeuw C, Jouault T, van Die I, Gosset P, Trottein F.

Infect Immun. 2007 Nov;75(11):5148-57. Epub 2007 Sep 4.

38.

Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.

Mallevaey T, Fontaine J, Breuilh L, Paget C, Castro-Keller A, Vendeville C, Capron M, Leite-de-Moraes M, Trottein F, Faveeuw C.

Infect Immun. 2007 May;75(5):2171-80. Epub 2007 Mar 12.

39.

[Visual acuity and work and leisure abilities].

Zanlonghi X, Faveeuw C, Bizeau T, Massot A.

Rev Prat. 2006 Jun 15;56(11):1232-9. Review. French.

PMID:
16903524
40.

Activation of invariant NKT cells by the helminth parasite schistosoma mansoni.

Mallevaey T, Zanetta JP, Faveeuw C, Fontaine J, Maes E, Platt F, Capron M, de-Moraes ML, Trottein F.

J Immunol. 2006 Feb 15;176(4):2476-85.

41.

Differential expression of selectins by mouse brain capillary endothelial cells in vitro in response to distinct inflammatory stimuli.

Coisne C, Faveeuw C, Delplace Y, Dehouck L, Miller F, Cecchelli R, Dehouck B.

Neurosci Lett. 2006 Jan 16;392(3):216-20. Epub 2005 Oct 7.

PMID:
16214291
42.

Role of the natural killer T lymphocytes in Th2 responses during allergic asthma and helminth parasitic diseases.

Trottein F, Mallevaey T, Faveeuw C, Capron M, Leite-de-Moraes M.

Chem Immunol Allergy. 2006;90:113-127. doi: 10.1159/000088884. Review.

PMID:
16210906
43.

Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium.

Coisne C, Dehouck L, Faveeuw C, Delplace Y, Miller F, Landry C, Morissette C, Fenart L, Cecchelli R, Tremblay P, Dehouck B.

Lab Invest. 2005 Jun;85(6):734-46.

44.

Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response.

Gosset P, Pichavant M, Faveeuw C, Bureau F, Tonnel AB, Trottein F.

Eur J Immunol. 2005 May;35(5):1491-500.

45.

Role of the D prostanoid receptor 1 in the modulation of immune and inflammatory responses.

Trottein F, Faveeuw C, Gosset P, Angeli V.

Crit Rev Immunol. 2004;24(5):349-62. Review.

PMID:
15663363
46.

Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion.

Hervé M, Angeli V, Pinzar E, Wintjens R, Faveeuw C, Narumiya S, Capron A, Urade Y, Capron M, Riveau G, Trottein F.

Eur J Immunol. 2003 Oct;33(10):2764-72.

47.

Impact of the Yersinia pseudotuberculosis-derived mitogen (YPM) on the murine immune system.

Carnoy C, Loiez C, Faveeuw C, Grangette C, Desreumaux P, Simonet M.

Adv Exp Med Biol. 2003;529:133-5. No abstract available.

PMID:
12756744
48.

Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells.

Gosset P, Bureau F, Angeli V, Pichavant M, Faveeuw C, Tonnel AB, Trottein F.

J Immunol. 2003 May 15;170(10):4943-52.

49.

Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice.

Faveeuw C, Mallevaey T, Paschinger K, Wilson IB, Fontaine J, Mollicone R, Oriol R, Altmann F, Lerouge P, Capron M, Trottein F.

Eur J Immunol. 2003 May;33(5):1271-81.

50.

Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways.

Faveeuw C, Gosset P, Bureau F, Angeli V, Hirai H, Maruyama T, Narumiya S, Capron M, Trottein F.

Eur J Immunol. 2003 Apr;33(4):889-98.

Supplemental Content

Loading ...
Support Center